Rice Hall James & Associates’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.21M	Buy	515,623 +152,730	+42%	+$2.14M	0.39%	66
2025 Q1	$4.89M	Buy	362,893 +309,518	+580%	+$4.17M	0.29%	77
2024 Q4	$1.02M	Buy	+53,375	New	+$1.02M	0.06%	204